APA   Click to copy
Pol, S. U., Liang, S., Schweser, F., Dhanraj, R., Schubart, A., Preda, M., … Zivadinov, R. (2020). Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE mice. Experimental Neurology.

Chicago/Turabian   Click to copy
Pol, Suyog U., Serena Liang, F. Schweser, Ravendra Dhanraj, A. Schubart, Marilena Preda, M. Sveinsson, et al. “Subcutaneous Anti-CD20 Antibody Treatment Delays Gray Matter Atrophy in Human Myelin Oligodendrocyte Glycoprotein-Induced EAE Mice.” Experimental Neurology (2020).

MLA   Click to copy
Pol, Suyog U., et al. “Subcutaneous Anti-CD20 Antibody Treatment Delays Gray Matter Atrophy in Human Myelin Oligodendrocyte Glycoprotein-Induced EAE Mice.” Experimental Neurology, 2020.

@article{suyog2020a,
  title = {Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE mice},
  year = {2020},
  journal = {Experimental Neurology},
  author = {Pol, Suyog U. and Liang, Serena and Schweser, F. and Dhanraj, Ravendra and Schubart, A. and Preda, Marilena and Sveinsson, M. and Ramasamy, D. and Dwyer, M. and Weckbecker, G. and Zivadinov, R.}
}